Navigation Links
Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
Date:3/27/2013

Individuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine tumors, according to a new study by researchers from UCLA and the University of Florida. Their findings were published online March 22 in the journal Diabetes.

The researchers, from the Larry L. Hillblom Islet Research Center at UCLA and the Diabetes Center at the University of Florida, found that cell mass was increased approximately 40 percent in the pancreases of deceased organ donors who had Type 2 diabetes and who had been treated with incretin therapy. This widely used type of treatment takes advantage of the action of a gut hormone known as glucagon-like peptide 1 (GLP-1) to lower blood sugar in the body.

Although there have been conflicting reports on the effects of the incretin class of drugs on the pancreas in animal studies, this is the first study to note such changes in the human pancreas. The research was made possible by a unique research consortium called nPOD (Network for Pancreatic Organ Donors with Diabetes), led by Dr. Mark Atkinson, a professor of pathology and pediatrics at the University of Florida. The network, which is funded by the Juvenile Diabetes Research Foundation, obtains pancreases from deceased organ donors, with permission of their next of kin, to better understand diabetes by investigating tissues of those with the disease.

"There is an increasing appreciation that animal studies do not always predict findings in humans," said Dr. Peter Butler, director of UCLA's Hillblom Islet Research Center and chief of the endocrinology, diabetes and hypertension unit. "The nPOD program is therefore a very precious resource." The researchers examined the pancreases of 20 deceased organ donors with Type 2 diabetes. Eight had been treated for at least a year with incretin therapy, while th
'/>"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Frozen Food Production in the US Industry Market Research Report from IBISWorld has Been Updated
2. Moffitt researchers analyze HPV vaccination disparities among girls from low-income families
3. Penn research: Quitting marshmallow test can be a rational decision
4. Notre Dame researchers scoring a win-win with novel set of concussion diagnostic tools
5. GW professor researching ways to improve human tissue dissection, reduce blood transfusions
6. Researchers form new nerve cells &#8211 directly in the brain
7. Wake Forest Baptist research provides clues to alcohol addiction vulnerability
8. Research and Markets Announces the Release of Global Biobank (Biospecimen/Biorepository/Biopreservation) Market For Equipment & Media – Trends & Forecast to 2017
9. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
10. UW researchers discover the brain origins of variation in pathological anxiety
11. Researchers decode biology of blood and iron disorders mapping out novel future therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 DailyEndorphin is pleased to announce ... With this highly configurable new offering, DE's annual ... many components of its wellness programming for the entire ... , With this new module, annual clients may also ... Create participant surveys, (3) Continually report on participant progress ...
(Date:6/3/2015)... Foot and Ankle Specialists of the ... ( Clarksville Division ) was recently presented with the ... Wound Care (SAWC) and the American Podiatric Medical Association ... The Conference was held on April 29-May 3, 2015, ... Antonio, TX. , Dr. Casey Friske graduated from ...
(Date:6/3/2015)... evigilo, a world leader in delivering and developing ... by launching a new and enhanced content-centric website: ... logo depicting a sun-like image with a color movement ... Know. To Act. In time. The color palate, it ... borderless approach to alerting and delivering safety and sense ...
(Date:6/2/2015)... Concorde Career Colleges, Inc., announced today ... Bell will manage day-to-day operations for the privately held ... the opportunity to help our Concorde team deliver on ... Concorde in part due to reports like Beyond College ... in Memphis and Portland.” , Bell brings 14 years ...
(Date:6/2/2015)... On March 19th, 2015, LiveToBeSober.org held an ... of Legends at Detroit’s Ford Field. Hosted by former ... the goal of the conference was to raise awareness ... the benefits of effective professional rehabilitation programs. It also ... that are available to them in regards to the ...
Breaking Medicine News(10 mins):Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Concorde Career Colleges Announces New President and COO 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2
... A Boston University School of Medicine-led research team has ... Stem (iPS) cells, derived from mouse fibroblasts, by using ... the reprogramming process. The result is a powerful laboratory ... embryonic stem cell-like cells for clinical purposes such as ...
... the spinal column called the multifidus muscle may in fact ... to researchers at the University of California, San Diego School ... role of this poorly understood muscle has been published on ... Journal of Bone and Joint Surgery . , "The ...
... MORRIS PLAINS, N.J., Jan. 7 Immunomedics, Inc. ... focused on developing monoclonal antibodies to treat cancer and ... President and Chief Executive Officer, will be presenting at ... held in San Francisco, CA.Ms. Sullivan,s presentation, which is ...
... save on ice skating admission PHILADELPHIA, Jan. 7 ... families to attend this year,s Healthy Kids Fest on Sunday, ... Landing, from 1 p.m. to 5 p.m. Just in time ... fitness will feature music and free activities for the whole ...
... CKD Care and Your Practice Culture: Improve Your ... Association 2009 Annual Meeting, "CKD and Your ... in Baltimore, will include plenary sessions and interactive ... to today,s nephrology practitioners. RPA will convene ...
... Inc.,(NYSE: HI ) has appointed Jan ... on continuous improvement and operational excellence initiatives,across the ... team, reporting directly to President and CEO Kenneth ... recently serving as vice president of operations in ...
Cached Medicine News:Health News:Converting adult somatic cells to pluripotent stem cells using a single virus 2Health News:Unique skeletal muscle design contributes to spine stability 2Health News:Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference 3Health News:Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 2Health News:Renal Physicians Association 2009 Annual Meeting 2Health News:Hillenbrand, Inc. Appoints Jan Santerre Vice President of Lean Business 2
(Date:6/3/2015)... , June 3, 2015 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address rare diseases, ... Annual William Blair Growth Stock Conference to be held at ... , June 9-11, 2015. John Mendlein , ... presentation on the Company at 9:20 a.m. CT on Wednesday, ...
(Date:6/3/2015)... 3, 2015  GenVec, Inc. (NASDAQ: GNVC ) ... T. Curiel and his team from the School ... Louis (WUSTL).  Dr. Curiel is the director ... Division within the Department of Radiation Oncology. ... will create modified versions of GenVec,s gorilla adenovectors that ...
(Date:6/3/2015)... June 3, 2015  EIP Pharma LLC ( www.eippharma.com ... clinical development of VX-745 in Alzheimer,s disease (AD) is ... and potent inhibitor of the alpha isoform of the ... alpha). "Recent human genetic data demonstrate that ... with symptomatic Alzheimer,s, while the science also indicates the ...
Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... Telik, Inc. (Nasdaq: TELK ) today reported ...  The net loss for the quarter ended March 31, 2011 was $3.7 ... of $5.3 million, or $0.10 per share, for the same period ... in the first quarter of 2011 were $1.7 million, compared to ...
... WOONSOCKET, R.I., May 16, 2011 Obtaining prior authorization ... patients and pharmacists that currently requires phone calls, faxes ... available, they do not provide both a real-time solution ... electronic health record (EHR) tools.  Recognizing this gap in ...
Cached Medicine Technology:Telik Announces First Quarter 2011 Financial Results 2Telik Announces First Quarter 2011 Financial Results 3CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 2CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 3
... The Vision5L Digital ... 5- or 7-lead, ... a signal preview,screen. ... using a compact,flash ...
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... CSV-1000CVA test face is used to evaluate both ... levels (high, 25% and 12.5%) of LogMAR acuity ... face as well as the two spatial frequencies ... most widely used for cataract documentation because eye ...
... is used widely for screening refractive surgery ... from 20/10 to 20/100 and one row ... ,The patient can be easily screened in ... contrast sensitivity. If a contrast sensitivity deficit ...
Medicine Products: